Basilea meldet starke Finanzergebnisse für das erste Halbjahr 2021 mit deutlich erhöhtem Cashflow durch vermarktete Produkte und erhöht finanziellen Ausblick für Gesamtjahr 2021

NEXT STORY
Tiziana Announces Publication of a Peer Reviewed Article on Data from the Clinical Trial with Intranasally Administered Foralumab, Its Proprietary Fully Human Anti-CD3 Monoclonal Antibody, in Mild to Moderate COVID-19 Patients in Brazil
PREV STORY
Press release Biocartis Group NV: Second Update on Fire Incident at Biocartis Warehouse
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BeyondSpring Pharmaceuticals to Present Plinabulin-Immune System Interactions at AACR’s 2016 Tumor Microenvironment Special Conference

NEW YORK, Jan. 05, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage ...

author_avatar
NASDAQ Market News

SUMITOVANT BIOPHARMA ANNOUNCES THE APPOINTMENT OF INDUSTRY VETERAN, DAVID MAREK, AS CHIEF EXECUTIVE OFFICER OF MYOVANT SCIENCES

author_avatar
NASDAQ Market News

Strongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference

DUBLIN, Ireland and TREVOSE, Pa., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc ...

author_avatar
NASDAQ Market News